APAC - Epilepsy Therapeutic Market by Distribution Channel and Product - Forecast and Analysis 2024-2028

1 Executive Summary

• 1.1 Market overview
  • Exhibit 01: Executive Summary – Chart on Market Overview
  • Exhibit 02: Executive Summary – Data Table on Market Overview
  • Exhibit 03: Executive Summary – Chart on Country Market Characteristics
  • Exhibit 04: Executive Summary – Chart on Market by Geography
  • Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
  • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
  • Exhibit 07: Executive Summary – Chart on Incremental Growth
  • Exhibit 08: Executive Summary – Data Table on Incremental Growth
  • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
  • Exhibit 13: Market segments

• 3.3 Market size 2023

• 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on APAC - Market size and forecast 2023-2028 ($ million)
  • Exhibit 15: Data Table on Regional - Market size and forecast 2023-2028 ($ million)
  • Exhibit 16: Chart on APAC: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Regional - Market size and forecast 2023-2028 ($ million)

4 Historic Market Size

• 4.1 epilepsy therapeutics market in APAC 2018 - 2022
  • Exhibit 18: Historic Market Size – Data Table on epilepsy therapeutics market in APAC 2018 - 2022 ($ million)

• 4.2 Distribution Channel Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ million)

• 4.3 Product Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size – Product Segment 2018 - 2022 ($ million)

• 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Exhibit 22: Five forces analysis - Comparison between 2023 and 2028

• 5.2 Bargaining power of buyers
  • Exhibit 23: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

• 5.3 Bargaining power of suppliers
  • Exhibit 24: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

• 5.4 Threat of new entrants
  • Exhibit 25: Threat of new entrants – Impact of key factors in 2023 and 2028

• 5.5 Threat of substitutes
  • Exhibit 26: Threat of substitutes – Impact of key factors in 2023 and 2028

• 5.6 Threat of rivalry
  • Exhibit 27: Threat of rivalry – Impact of key factors in 2023 and 2028

• 5.7 Market condition
  • Exhibit 28: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

• 6.1 Market segments
  • Exhibit 29: Chart on Distribution Channel - Market share 2023-2028 (%)
  • Exhibit 30: Data Table on Distribution Channel - Market share 2023-2028 (%)

• 6.2 Comparison by Distribution Channel
  • Exhibit 31: Chart on Comparison by Distribution Channel
  • Exhibit 32: Data Table on Comparison by Distribution Channel

• 6.3 Hospital pharmacy - Market size and forecast 2023-2028
  • Exhibit 33: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
  • Exhibit 34: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
  • Exhibit 35: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibit 36: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)

• 6.4 Retail pharmacy - Market size and forecast 2023-2028
  • Exhibit 37: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
  • Exhibit 38: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
  • Exhibit 39: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibit 40: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)

• 6.5 Online pharmacy - Market size and forecast 2023-2028
  • Exhibit 41: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
  • Exhibit 42: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
  • Exhibit 43: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibit 44: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)

• 6.6 Market opportunity by Distribution Channel
  • Exhibit 45: Market opportunity by Distribution Channel ($ million)
  • Exhibit 46: Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
  • Exhibit 47: Chart on Product - Market share 2023-2028 (%)
  • Exhibit 48: Data Table on Product - Market share 2023-2028 (%)

• 7.2 Comparison by Product
  • Exhibit 49: Chart on Comparison by Product
  • Exhibit 50: Data Table on Comparison by Product

• 7.3 First-generation epilepsy therapeutics - Market size and forecast 2023-2028
  • Exhibit 51: Chart on First-generation epilepsy therapeutics - Market size and forecast 2023-2028 ($ million)
  • Exhibit 52: Data Table on First-generation epilepsy therapeutics - Market size and forecast 2023-2028 ($ million)
  • Exhibit 53: Chart on First-generation epilepsy therapeutics - Year-over-year growth 2023-2028 (%)
  • Exhibit 54: Data Table on First-generation epilepsy therapeutics - Year-over-year growth 2023-2028 (%)

• 7.4 Second-generation epilepsy therapeutics - Market size and forecast 2023-2028
  • Exhibit 55: Chart on Second-generation epilepsy therapeutics - Market size and forecast 2023-2028 ($ million)
  • Exhibit 56: Data Table on Second-generation epilepsy therapeutics - Market size and forecast 2023-2028 ($ million)
  • Exhibit 57: Chart on Second-generation epilepsy therapeutics - Year-over-year growth 2023-2028 (%)
  • Exhibit 58: Data Table on Second-generation epilepsy therapeutics - Year-over-year growth 2023-2028 (%)

• 7.5 Third-generation epilepsy therapeutics - Market size and forecast 2023-2028
  • Exhibit 59: Chart on Third-generation epilepsy therapeutics - Market size and forecast 2023-2028 ($ million)
  • Exhibit 60: Data Table on Third-generation epilepsy therapeutics - Market size and forecast 2023-2028 ($ million)
  • Exhibit 61: Chart on Third-generation epilepsy therapeutics - Year-over-year growth 2023-2028 (%)
  • Exhibit 62: Data Table on Third-generation epilepsy therapeutics - Year-over-year growth 2023-2028 (%)

• 7.6 Market opportunity by Product
  • Exhibit 63: Market opportunity by Product ($ million)
  • Exhibit 64: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Exhibit 65: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Exhibit 66: Chart on Market share by geography - 2023-2028 (%)
  • Exhibit 67: Data Table on Market share by geography - 2023-2028 (%)

• 9.2 Geographic comparison
  • Exhibit 68: Chart on Geographic comparison
  • Exhibit 69: Data Table on Geographic comparison

• 9.3 China - Market size and forecast 2023-2028
  • Exhibit 70: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 71: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 72: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibit 73: Data Table on China - Year-over-year growth 2023-2028 (%)

• 9.4 Japan - Market size and forecast 2023-2028
  • Exhibit 74: Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibit 75: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibit 76: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibit 77: Data Table on Japan - Year-over-year growth 2023-2028 (%)

• 9.5 India - Market size and forecast 2023-2028
  • Exhibit 78: Chart on India - Market size and forecast 2023-2028 ($ million)
  • Exhibit 79: Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Exhibit 80: Chart on India - Year-over-year growth 2023-2028 (%)
  • Exhibit 81: Data Table on India - Year-over-year growth 2023-2028 (%)

• 9.6 Australia - Market size and forecast 2023-2028
  • Exhibit 82: Chart on Australia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 83: Data Table on Australia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 84: Chart on Australia - Year-over-year growth 2023-2028 (%)
  • Exhibit 85: Data Table on Australia - Year-over-year growth 2023-2028 (%)

• 9.7 Rest of APAC - Market size and forecast 2023-2028
  • Exhibit 86: Chart on Rest of APAC - Market size and forecast 2023-2028 ($ million)
  • Exhibit 87: Data Table on Rest of APAC - Market size and forecast 2023-2028 ($ million)
  • Exhibit 88: Chart on Rest of APAC - Year-over-year growth 2023-2028 (%)
  • Exhibit 89: Data Table on Rest of APAC - Year-over-year growth 2023-2028 (%)

• 9.8 Market opportunity by geography
  • Exhibit 90: Market opportunity by geography ($ million)
  • Exhibit 91: Data Table on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges
  • Exhibit 92: Impact of drivers and challenges in 2023 and 2028

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
  • Exhibit 93: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
  • Exhibit 94: Overview on factors of disruption

• 11.4 Industry risks
  • Exhibit 95: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
  • Exhibit 96: Vendors covered

• 12.2 Market positioning of vendors
  • Exhibit 97: Matrix on vendor position and classification

• 12.3 Bausch Health Companies Inc.
  • Exhibit 98: Bausch Health Companies Inc. - Overview
  • Exhibit 99: Bausch Health Companies Inc. - Business segments
  • Exhibit 100: Bausch Health Companies Inc. - Key news
  • Exhibit 101: Bausch Health Companies Inc. - Key offerings
  • Exhibit 102: Bausch Health Companies Inc. - Segment focus

• 12.4 BIAL
  • Exhibit 103: BIAL - Overview
  • Exhibit 104: BIAL - Product / Service
  • Exhibit 105: BIAL - Key offerings

• 12.5 Dr Reddys Laboratories Ltd.
  • Exhibit 106: Dr Reddys Laboratories Ltd. - Overview
  • Exhibit 107: Dr Reddys Laboratories Ltd. - Business segments
  • Exhibit 108: Dr Reddys Laboratories Ltd. - Key offerings
  • Exhibit 109: Dr Reddys Laboratories Ltd. - Segment focus

• 12.6 Eisai Co. Ltd.
  • Exhibit 110: Eisai Co. Ltd. - Overview
  • Exhibit 111: Eisai Co. Ltd. - Business segments
  • Exhibit 112: Eisai Co. Ltd. - Key offerings
  • Exhibit 113: Eisai Co. Ltd. - Segment focus

• 12.7 GlaxoSmithKline Plc
  • Exhibit 114: GlaxoSmithKline Plc - Overview
  • Exhibit 115: GlaxoSmithKline Plc - Business segments
  • Exhibit 116: GlaxoSmithKline Plc - Key news
  • Exhibit 117: GlaxoSmithKline Plc - Key offerings
  • Exhibit 118: GlaxoSmithKline Plc - Segment focus

• 12.8 H Lundbeck AS
  • Exhibit 119: H Lundbeck AS - Overview
  • Exhibit 120: H Lundbeck AS - Product / Service
  • Exhibit 121: H Lundbeck AS - Key offerings

• 12.9 Johnson and Johnson
  • Exhibit 122: Johnson and Johnson - Overview
  • Exhibit 123: Johnson and Johnson - Business segments
  • Exhibit 124: Johnson and Johnson - Key news
  • Exhibit 125: Johnson and Johnson - Key offerings
  • Exhibit 126: Johnson and Johnson - Segment focus

• 12.10 Novartis AG
  • Exhibit 127: Novartis AG - Overview
  • Exhibit 128: Novartis AG - Business segments
  • Exhibit 129: Novartis AG - Key offerings
  • Exhibit 130: Novartis AG - Segment focus

• 12.11 Pfizer Inc.
  • Exhibit 131: Pfizer Inc. - Overview
  • Exhibit 132: Pfizer Inc. - Product / Service
  • Exhibit 133: Pfizer Inc. - Key news
  • Exhibit 134: Pfizer Inc. - Key offerings

• 12.12 Sanofi SA
  • Exhibit 135: Sanofi SA - Overview
  • Exhibit 136: Sanofi SA - Business segments
  • Exhibit 137: Sanofi SA - Key news
  • Exhibit 138: Sanofi SA - Key offerings
  • Exhibit 139: Sanofi SA - Segment focus

• 12.13 SK Inc.
  • Exhibit 140: SK Inc. - Overview
  • Exhibit 141: SK Inc. - Product / Service
  • Exhibit 142: SK Inc. - Key offerings

• 12.14 Sumitomo Pharma Co. Ltd.
  • Exhibit 143: Sumitomo Pharma Co. Ltd. - Overview
  • Exhibit 144: Sumitomo Pharma Co. Ltd. - Business segments
  • Exhibit 145: Sumitomo Pharma Co. Ltd. - Key offerings
  • Exhibit 146: Sumitomo Pharma Co. Ltd. - Segment focus

• 12.15 Sun Pharmaceutical Industries Ltd.
  • Exhibit 147: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibit 148: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibit 149: Sun Pharmaceutical Industries Ltd. - Key offerings

• 12.16 Teva Pharmaceutical Industries Ltd.
  • Exhibit 150: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibit 151: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibit 152: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibit 153: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibit 154: Teva Pharmaceutical Industries Ltd. - Segment focus

• 12.17 UCB SA
  • Exhibit 155: UCB SA - Overview
  • Exhibit 156: UCB SA - Product / Service
  • Exhibit 157: UCB SA - Key offerings

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist
  • Exhibit 158: Inclusions checklist
  • Exhibit 159: Exclusions checklist

• 13.3 Currency conversion rates for US$
  • Exhibit 160: Currency conversion rates for US$

• 13.4 Research methodology
  • Exhibit 161: Research methodology
  • Exhibit 162: Validation techniques employed for market sizing
  • Exhibit 163: Information sources

• 13.5 List of abbreviations
  • Exhibit 164: List of abbreviations